CEO Michael O'Connor of Rainmaker Worldwide Inc., discusses patented water technologies, including Air-to-Water and Water-to-Water products, that produce clean water wherever it's needed.
VP, Corporate Development Scott Curtis of Antibe Therapeutics, Inc., discusses safer non-steroidal anti-inflammatory drugs or NSAIDs, with a focus on their lead drug ATB-346.
COO Dr. Catherine Hickson of Dajin Resources Corp., discusses lithium exploration in Nevada and Argentina, with a focus on brine assets.
CEO Dr. Richard Spencer of U3O8 Corp., gives an update on the price of Uranium, it's growing demand, and other minerals for use in electric batteries.
CEO George Fink of Bonterra Energy Corp., discusses being a high-yield, dividend paying oil and gas company.
CEO Steven Rossi of Franchise Holdings International, Inc., gives details on plans for mergers and acquisitions as well as building tonneau cover manufacturer based revenues.
CEO Trent Mell of First Cobalt Corp , gives an update on the recent merger with U.S. Cobalt, what it means to the company, and the growing international market for Cobalt.
CEO Dr. Richard Spencer of U3O8 Corp., gives details on being a Green resources company with Uranium and other battery commodities projects.
CEO Dr. Mark Day of Bioasis Technologies Inc., gives details on developing xB3 for treatment of brain cancer and neurodegenerative disease.
CEO Dr. Gene Cartwright of Guided Therapeutics, Inc., talks about their rapid and painless cervical cancer detection testing device LuViva and the international market for sales.
CEO Trent Mell of First Cobalt Corp, talks about the possible acquisition of U.S. Cobalt and becoming the go to producer of Cobalt in North America.
CEO Michael Friedman of Agritek Holdings, Inc., speaks about real estate management and health and wellness product lines.